Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Tandem Diabetes (TNDM) Tops Q4 EPS by 11c, Offers FY Guidance
February 24, 2016 4:15 PM ESTTandem Diabetes (NASDAQ: TNDM) reported Q4 EPS of ($0.40), $0.11 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $29.1 million versus the consensus estimate of $29.17 million.
GUIDANCE:
Tandem Diabetes sees FY2016 revenue of $105-112 million, versus... More
